Why the study?
Does aggressive treatment improve outcomes in patients aged 75 years or older with acute myocardial infarction?
Does aggressive treatment improve outcomes in patients aged 75 years or older with acute myocardial infarction?
This review discusses the rationale, patient selection, and methods for aggressive treatment of acute myocardial infarction in patients aged 75 years or older.
May guide selection for aggressive AMI therapy in patients ≥75; leaves open the need for dedicated randomized outcome data.
The progressive aging of the population is associated with an increase in the proportion of very old patients (greater than 75 years) hospitalized with acute myocardial infarction. The lack of evidence regarding the efficacy of most therapeutic interventions for acute myocardial infarction in these patients is leading to a significant degree of uncertainty in the cardiology community with respect to their optimal management. When aggressive treatment (defined as a therapeutic strategy designed to obtain and maintain a patent infarct-related coronary artery at an early moment) of acute myocardial infarction is considered in very old patients, three main questions should be addressed: why should we treat? Whom should we treat? And how should we treat? To answer these questions, the authors reviewed the data available in the literature as well as new data from the PPRIMM75 (Pronóstico del PRimer Infarto de Miocardio en Mayores de 75 aÃ+/-os) Registry, a large, prospective database of patients aged 75 years or older, admitted to a single coronary care unit in Madrid, Spain, for their first acute myocardial infarction during the last decade.
No takes yet. Share an insight, caveat, or question.
Héctor Bueno (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: